Descripción
HieffTM LongSeq Plasmid Fragmentation and Ligation Module is a dedicated enzymatic module developed for third-generation Nanopore sequencing platforms. When used in combination with Cat. No. 13304ES, it enables streamlined plasmid library construction.
This kit is optimized specifically for plasmid DNA library preparation. Following enzymatic fragmentation, end repair, and dA-tailing, no purification step is required—samples can proceed directly to barcode ligation, significantly simplifying the workflow.
Features
- Wide input range: 50 ng – 1 µg plasmid DNA
- Fast workflow: ~2 hours from DNA to library
- Enzyme-based fragmentation: controlled, low-damage digestion
- Long-read friendly: preserves plasmid integrity and long inserts
- Consistent performance: strict batch-to-batch quality control
Components
|
Components NO. |
Name |
13305ES08 |
13305ES24 |
13305ES96 |
|
|
|
|
8 T |
24 T |
96 T |
|
|
13305-A |
|
80 μL |
240 μL |
960 μL |
|
|
13305-B |
|
SmearaseTM Enzyme |
40 μL |
120 μL |
480 μL |
|
13305-C |
|
Rapid Ligase Master Mix |
280 μL |
840 μL |
4×840 μL |
Storage
This product should be stored at -25~-15℃ for one year.
Figure
Excellent Nanopore sequencing performance
Sequencing Size Distribution
Figure 1. High-Quality Nanopore Sequencing of Plasmid Libraries Prepared Using Yeasen Enzymatic Fragmentation(13305ES+13304ES).
Plasmid libraries were prepared from 100–200 ng input DNA through a rapid 2-minute enzymatic fragmentation process. The resulting libraries achieved an N50 of 2–5 kb, showcasing robust and reproducible long-read sequencing performance on Oxford Nanopore platforms.
Documents:
Safety Data Sheet
Manuals
13305_Manual_Ver.EN20260302.pdf
Related Blog:
Full-Length Plasmid Sequencing Made Easy: Verify Your Plasmids with Co
Pago y seguridad
Su información de pago se procesa de forma segura. No almacenamos detalles de la tarjeta de crédito ni tenemos acceso a la información de su tarjeta de crédito.
También te puede gustar
Consulta
Preguntas frecuentes
El producto es solo para fines de investigación y no está destinado a uso terapéutico o diagnóstico en humanos o animales. Los productos y el contenido están protegidos por patentes, marcas comerciales y derechos de autor propiedad de Yeasen Biotechnology. Los símbolos de marca comercial indican el país de origen, no necesariamente el registro en todas las regiones.
Algunas aplicaciones pueden requerir derechos de propiedad intelectual adicionales de terceros.
Yeasen se dedica a la ciencia ética y cree que nuestra investigación debe abordar cuestiones críticas al tiempo que garantiza la seguridad y los estándares éticos.